2022
DOI: 10.31533/pubsaude9.a345
|View full text |Cite
|
Sign up to set email alerts
|

Costs analysis of hip osteonecrosis treatment: cell therapy and total arthroplasty in people with sickle cell disease from the SUS perspective

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles